Articles de revue sur le cancer du rein - Dernières parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer du rein (10 février 2008):

Role of sunitinib and sorafenib in the treatment of metastatic renal
cell carcinoma.
Hiles JJ, Kolesar JM.
Am J Health Syst Pharm. 2008 Jan 15;65(2):123-31.

VHL inactivation in renal cell carcinoma: implications for diagnosis,
prognosis and treatment.
Rathmell WK, Chen S.
Expert Rev Anticancer Ther. 2008 Jan;8(1):63-73.

Cancer risk in nuclear workers occupationally exposed to uranium-
emphasis on internal exposure.
Canu IG, Ellis ED, Tirmarche M.
Health Phys. 2008 Jan;94(1):1-17.

Primary renal botryoid rhabdomyosarcoma: diagnosis and outcome.
Sola JE, Cova D, Casillas J, Alvarez OA, Qualman S, Rodriguez MM.
J Pediatr Surg. 2007 Dec;42(12):e17-20.

Radiolabeled antibodies in renal cell carcinoma.
Stillebroer AB, Oosterwijk E, Oyen WJ, Mulders PF, Boerman OC.
Cancer Imaging. 2007 Nov 19;7:179-88.

Role of the ubiquitin proteasome system in renal cell carcinoma.
Corn PG.
BMC Biochem. 2007 Nov 22;8 Suppl 1:S4.

Growing opportunities for adjuvant therapy of renal cell carcinoma:
targeted drugs and vaccines.
Rodriguez AR, Fishman MN.
Expert Opin Pharmacother. 2007 Dec;8(17):2979-90.

Molecular mechanisms underlying the MiT translocation subgroup of
renal cell carcinomas.
Medendorp K, van Groningen JJ, Schepens M, Vreede L, Thijssen J,
Schoenmakers EF, van den Hurk WH, Geurts van Kessel A, Kuiper RP.
Cytogenet Genome Res. 2007;118(2-4):157-65.

Positron emission tomography and positron emission tomography/
computerized tomography of urological malignancies: an update review.
Bouchelouche K, Oehr P.
J Urol. 2008 Jan;179(1):34-45.

Temsirolimus.
Ma WW, Jimeno A.
Drugs Today (Barc). 2007 Oct;43(10):659-69.

Emerging drugs for the treatment of metastatic renal cancer.
Samlowski WE, Vogelzang NJ.
Expert Opin Emerg Drugs. 2007 Nov;12(4):605-18.


Sorafenib: a promising new targeted therapy for renal cell carcinoma.
Wood LS, Manchen B.
Clin J Oncol Nurs. 2007 Oct;11(5):649-56.

The role of vascular endothelial growth factor in kidney and prostate
cancer.
Delongchamps NB, Peyromaure M.
Can J Urol. 2007 Oct;14(5):3669-77.

Potential clinical applications of epothilones: a review of phase II
studies.
Larkin JM, Kaye SB.
Ann Oncol. 2007 Jul;18 Suppl 5:v28-34.

Evolving role of novel targeted agents in renal cell carcinoma.
Hutson TE, Figlin RA.
Oncology (Williston Park). 2007 Sep;21(10):1175-80

Renal cell cancer.
Hutson TE, Figlin RA.
Cancer J. 2007 Sep-Oct;13(5):282-6.



(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)